399 related articles for article (PubMed ID: 25463194)
1. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
[TBL] [Abstract][Full Text] [Related]
2. A new metabolomic workflow for early detection of Alzheimer's disease.
Ibáñez C; Simó C; Barupal DK; Fiehn O; Kivipelto M; Cedazo-Mínguez A; Cifuentes A
J Chromatogr A; 2013 Aug; 1302():65-71. PubMed ID: 23827464
[TBL] [Abstract][Full Text] [Related]
3. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
[TBL] [Abstract][Full Text] [Related]
4. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
Zhang T; Watson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
[TBL] [Abstract][Full Text] [Related]
6. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
[TBL] [Abstract][Full Text] [Related]
7. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
8. Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics.
Ibáñez C; Simó C; Martín-Álvarez PJ; Kivipelto M; Winblad B; Cedazo-Mínguez A; Cifuentes A
Anal Chem; 2012 Oct; 84(20):8532-40. PubMed ID: 22967182
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic applications of HILIC-LC-MS.
Cubbon S; Antonio C; Wilson J; Thomas-Oates J
Mass Spectrom Rev; 2010; 29(5):671-84. PubMed ID: 19557839
[TBL] [Abstract][Full Text] [Related]
10. Sample preparation and orthogonal chromatography for broad polarity range plasma metabolomics: application to human subjects with neurodegenerative dementia.
Armirotti A; Basit A; Realini N; Caltagirone C; Bossù P; Spalletta G; Piomelli D
Anal Biochem; 2014 Jun; 455():48-54. PubMed ID: 24708938
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics.
Wernisch S; Pennathur S
Anal Bioanal Chem; 2016 Sep; 408(22):6079-91. PubMed ID: 27370688
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic interaction chromatography-mass spectrometry for anionic metabolic profiling of urine from antibiotic-treated rats.
Kok MG; Swann JR; Wilson ID; Somsen GW; de Jong GJ
J Pharm Biomed Anal; 2014 Apr; 92():98-104. PubMed ID: 24503197
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics.
Cui Y; Liu X; Wang M; Liu L; Sun X; Ma L; Xie W; Wang C; Tang S; Wang D; Wu Q
J Neuropathol Exp Neurol; 2014 Oct; 73(10):954-63. PubMed ID: 25192049
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry.
Li NJ; Liu WT; Li W; Li SQ; Chen XH; Bi KS; He P
Clin Biochem; 2010 Aug; 43(12):992-7. PubMed ID: 20457143
[TBL] [Abstract][Full Text] [Related]
15. Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.
Ciborowski M; Kisluk J; Pietrowska K; Samczuk P; Parfieniuk E; Kowalczyk T; Kozlowski M; Kretowski A; Niklinski J
Electrophoresis; 2017 Sep; 38(18):2304-2312. PubMed ID: 28440547
[TBL] [Abstract][Full Text] [Related]
16. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
17. Processing and analysis of GC/LC-MS-based metabolomics data.
Want E; Masson P
Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
[TBL] [Abstract][Full Text] [Related]
18. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
19. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
20. A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine.
Zhang T; Watson DG
Analyst; 2015 May; 140(9):2907-15. PubMed ID: 25756251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
